Representative before the EPO

Employment test 51 - 200 employees
Company dna mewburn ellis llp
operating since 1890
Headquarter in London and 4 offices
active in Legal Services

Lindsey Claire Woolley has worked on the following 54 EPO patent applications which have been published in the last five years:

EP11748246

INCREASING PLANT GROWTH BY MODULATING OMEGA-AMIDASE EXPRESSION IN PLANTS

IPC classification:
A01H 5/00, C12N 15/82
Applicant:
University of Maine System Board of Trustees
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP11769579

ANTI-POLYUBIQUITIN ANTIBODIES AND METHODS OF USE

IPC classification:
A61K 39/395, C07K 16/18
Applicant:
Genentech, Inc.
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP11754597

BIOMARKERS AND METHODS OF TREATMENT

IPC classification:
A61K 39/00, G01N 33/574
Applicant:
Genentech, Inc.
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
The patent has been granted
EP12178200

Prevention of disulfide bond reduction during recombinant production of polypeptides

IPC classification:
C07K 1/00, C07K 14/00
Applicant:
Genentech, Inc.
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP11807376

SQUASH LEAF CURL VIRUS (SLCV) RESISTANCE IN CUCURBITS

IPC classification:
A01H 1/00, A01H 1/04, A01H 5/00
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13154283

Antagonist anti-Notch3 antibodies and their use in the prevention and treatment of Notch3-related diseases

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/28, C12N 5/12, C12N 15/13
Applicant:
Genentech, Inc.
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13165235

Apoptotic anti-IgE antibodies

IPC classification:
A01K 67/027, A61P 37/06, C07K 16/42
Applicant:
Genentech, Inc.
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13183384

Anti-FGFR3 antibodies and methods using same

IPC classification:
A61K 39/395, C07K 16/28
Applicant:
Genentech, Inc.
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12781555

CD44 MONOCLONAL ANTIBODY FOR THE TREATMENT OF B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA AND OTHER HEMATOLOGICAL MALIGNANCIES

IPC classification:
A61K 39/395, A61P 35/00, A61P 35/02, C07K 16/28
Applicant:
The Regents of the University of California
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12844824

INHIBITION OF COLLAGEN SYNTHESIS

IPC classification:
A61K 38/17, C07K 14/47
Applicant:
University of Manitoba Technology Transfer Office
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12787307

DRUG SCREENING AND POTENCY ASSAYS

IPC classification:
C12N 5/00, G01N 33/50
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13162222

Biochemical analysis of partitioned cells

IPC classification:
C12Q 1/68
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14166919

Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis

IPC classification:
A61K 38/17, C07K 14/47, C07K 14/705, C07K 16/18, C07K 16/28, C12N 15/12, C12N 15/62, C12Q 1/68, G01N 33/53
Applicant:
Genentech, Inc.
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11807988

PHYTOPHTHORA RESISTANCE IN SWEET PEPPERS

IPC classification:
A01H 5/00, C12Q 1/68
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13761535

TOOL AND METHOD FOR REPAIRING TUBULAR MEMBERS

IPC classification:
B24B 19/02, B29C 73/02, B29C 73/30, A63B 59/14
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP13716131

ANTI-LGR5 ANTIBODIES AND IMMUNOCONJUGATES

IPC classification:
A61K 47/48, A61P 35/00, C07K 16/28
Applicant:
Genentech, Inc.
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12822145

ANTI-POLYUBIQUITIN ANTIBODIES AND METHODS OF USE

IPC classification:
A61K 39/395, C07K 16/18
Applicant:
Genentech, Inc.
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13785317

OPEN-ENDED RATCHET WRENCH

IPC classification:
B25B 13/02, B25B 13/08, B25B 13/46
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13721529

ANTI-PMEL17 ANTIBODIES AND IMMUNOCONJUGATES

IPC classification:
A61K 47/48, C07K 16/28, C07K 16/30
Applicant:
Genentech, Inc.
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13174782

Plant superoxide dismutase expression resistant to micro-RNA regulation

IPC classification:
C12N 5/12, C12N 15/12, C12N 15/52
Applicant:
The Regents of the University of California
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14189582

Methods for removing a contaminant using indigenous protein displacement ion exchange membrane chromatography

IPC classification:
C07K 1/18, C07K 1/34, C07K 1/36
Applicant:
Genentech, Inc.
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13724493

HIGH-CONCENTRATION MONOCLONAL ANTIBODY FORMULATIONS

IPC classification:
A61K 9/00, A61K 9/10, A61K 9/16
Applicant:
Genentech, Inc.
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP11793523

INJECTABLE FORMULATIONS FOR ORGAN AUGMENTATION

IPC classification:
A61L 27/22, A61L 27/38, A61L 27/50, A61L 27/52
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP13737118

IMMUNOCONJUGATES COMPRISING ANTI - CD79B ANTIBODIES

IPC classification:
A61K 47/48, A61P 35/00
Applicant:
Genentech, Inc.
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13739333

IMMUNOCONJUGATES COMPRISING ANTI-CD22 ANTIBODIES

IPC classification:
A61K 47/48, A61P 35/00
Applicant:
Genentech, Inc.
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP13739332

IMMUNOCONJUGATES COMPRISING ANTI-CD79B ANTIBODIES

IPC classification:
A61K 47/48, A61P 35/00
Applicant:
Genentech, Inc.
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13739331

IMMUNOCONJUGATES COMPRISING ANTI-CD22 ANTIBODIES

IPC classification:
A61K 47/48, A61P 35/00
Applicant:
Spirogen Sàrl
Applicant:
MedImmune Limited
Applicant:
Genentech, Inc.
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP13826433

ANTI-ETBR ANTIBODIES AND IMMUNOCONJUGATES

IPC classification:
A61K 39/395
Applicant:
Genentech, Inc.
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13786132

RENAL CELL POPULATIONS AND USES THEREOF

IPC classification:
C12N 5/071
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13865282

HYDROPHILIC SELF-IMMOLATIVE LINKERS AND CONJUGATES THEREOF

IPC classification:
A61K 31/496, A61P 35/00, C07D 295/192, C07D 417/14, C07K 17/06
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14743859

TISSUE PLASMINOGEN ACTIVATOR ANTIBODIES AND METHODS OF USE THEREOF

IPC classification:
A61K 38/36, A61P 7/04, C07K 14/75
Applicant:
University of Tennessee Research Foundation
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Agent:
Kerry Linda Verhorevoort, Bridle Intellectual Property Ltd
Status:
GRANT OF PATENT INTENDED
EP14717318

ANTI-B7-H4 ANTIBODIES AND IMMUNOCONJUGATES

IPC classification:
A61K 39/395, A61K 47/48, A61P 35/00, C07K 16/28
Applicant:
Genentech, Inc.
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14742047

ANTI-FCRH5 ANTIBODIES

IPC classification:
A61K 39/395, A61K 47/48, C07K 16/28
Applicant:
Genentech, Inc.
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14752733

DELIVERY NEEDLE WITH ELEVATOR/PADDLE FOR MICRONIZED ALLOGRAFT TISSUE

IPC classification:
A61B 17/56
Applicant:
Arthrex Inc
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14752732

MENISCAL PROBE CUTTER

IPC classification:
A61B 17/3207
Applicant:
Arthrex Inc
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14856653

ANTI-Ly6E ANTIBODIES AND METHODS OF USE

IPC classification:
A61K 39/395
Applicant:
Genentech, Inc.
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP12171840

Highly multiplexed particle-based assays

IPC classification:
G01N 33/53, G01N 33/68
Agent:
James Christopher Legg, Avidity IP Ltd
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Agent:
James Christopher Legg, Boult Wade Tennant Ltd
Status:
PATENT GRANTED
EP14824269

ANTI-CD33 ANTIBODIES AND IMMUNOCONJUGATES

IPC classification:
A61K 39/395, A61P 35/02, C07K 16/28
Applicant:
Genentech, Inc.
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14869424

ANTI-SIGLEC-8 ANTIBODIES AND METHODS OF USE THEREOF

IPC classification:
A61K 39/395, A61P 37/00, C07K 16/28
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14828608

ANTI-CD3 ANTIBODIES AND METHODS OF USE

IPC classification:
A61K 39/395, A61P 35/00, A61P 37/00, C07K 16/28, C07K 16/30, C07K 16/32
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP16159976

BISPECIFIC ANTI-HER ANTIBODIES

IPC classification:
C07K 16/28, C07K 16/32
Applicant:
F. Hoffmann-La Roche AG
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
APPLICATION PUBLISHED
EP15755175

METHODS AND COMPOSITIONS FOR TREATING SIGLEC-8 ASSOCIATED DISEASES

IPC classification:
A61K 39/395, A61P 37/00
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP16185385

COMBINED AUTOLOGOUS BIOLOGIC AND COLD THERAPY TREATMENT OF SKIN INJURIES

IPC classification:
A61F 2/10, A61J 1/14, A61K 35/19, A61L 27/36, F25D 3/08
Applicant:
Arthrex Inc
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
Request for examination was made
EP16196757

BIOACTIVE RENAL CELLS

IPC classification:
C12N 5/071, C12N 15/113, C12Q 1/68
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
The application has been published
EP15772090

ANTI-HER2 ANTIBODIES AND IMMUNOCONJUGATES

IPC classification:
A61P 35/00, C07K 16/32, A61K 47/50
Applicant:
Genentech, Inc.
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
Request for examination was made
EP15770739

ANTI-CLL-1 ANTIBODIES AND IMMUNOCONJUGATES

IPC classification:
A61P 35/02, C07K 16/28, C07K 16/30, A61K 47/50
Applicant:
Genentech, Inc.
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
Request for examination was made
EP15767037

ANTI-B7-H4 ANTIBODIES AND IMMUNOCONJUGATES

IPC classification:
C07K 16/28, C07K 16/30, A61K 47/50
Applicant:
Genentech, Inc.
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
Request for examination was made
EP15779065

IMMUNOCONJUGATES COMPRISING ANTI-HER2 ANTIBODIES AND PYRROLOBENZODIAZEPINES

IPC classification:
A61P 35/00, A61K 47/50
Applicant:
Genentech, Inc.
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
Request for examination was made
EP17156352

ANTI-CD3 ANTIBODIES AND METHODS OF USE

IPC classification:
A61K 39/395, A61P 35/00, A61P 37/00, C07K 16/28, C07K 16/30, C07K 16/32
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
The application has been published
EP16205172

EXPRESSION OF SURROGATE LIGHT CHAINS

IPC classification:
C07K 14/705, C12N 15/10
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
The application has been published
EP15797531

METHODS OF PRODUCING TWO CHAIN PROTEINS IN BACTERIA

IPC classification:
C07K 16/00, C07K 16/22, C07K 16/24, C07K 16/28, C12N 15/63, C12P 21/00
Applicant:
Genentech, Inc.
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
Request for examination was made
EP17152167

COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES

IPC classification:
A61P 37/02, C07K 14/705, C07K 16/28, G01N 33/50, G01N 33/564, G01N 33/569
Applicant:
Genentech, Inc.
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
The application has been published
EP15805020

ANTIBODIES AGAINST BACE1 AND USE THEREOF FOR NEURAL DISEASE IMMUNOTHERAPY

IPC classification:
A61K 39/395, A61P 25/28, C07K 16/40
Applicant:
Genentech, Inc.
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
Request for examination was made
EP15804651

ANTI-TRANSFERRIN RECEPTOR / ANTI-BACE1 MULTISPECIFIC ANTIBODIES AND METHODS OF USE

IPC classification:
A61K 39/395, A61P 25/00, C07K 16/28, C07K 16/40, C07K 16/46, C12N 15/13
Applicant:
Genentech, Inc.
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
Request for examination was made

Please Sign in to use this feature